High-sensitivity cardiac troponin I is a biomarker for increased arterial stiffness in systemic lupus erythematous women with normal kidney function-Reference-Cited by-同舟云学术

High-sensitivity cardiac troponin I is a biomarker for increased arterial stiffness in systemic lupus erythematous women with normal kidney function

Published:2022-09-12 Issue:2 Volume:43 Page:253-263
ISSN:1437-160X
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Sabio J. M.^ORCID,Garcia-de los Ríos Carlos^ORCID,Medina-Casado Marta,del Mar Del Águila-García María^ORCID,Cáliz-Cáliz Rafael^ORCID,Díaz-Chamorro Antonio^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s00296-022-05204-2.pdf

Reference48 articles.

1. Gu MM, Wang XP, Cheng QY, Zhao YL, Zhang TP, Li BZ, Ye DQ (2019) A meta-analysis of cardiovascular events in systemic lupus erythematosus. Immunol Investig 48(5):505–520. https://doi.org/10.1080/08820139.2019.1567534

2. Etchegaray-Morales I, Mendoza-Pinto C, Munguía-Realpozo P et al (2022) Systemic lupus erythematosus, a leading cause of death in young Mexican females: a nationwide population-based study, 2000–2020. Rheumatol Int. https://doi.org/10.1007/s00296-022-05154-9

3. Thomas G, Mancini J, Jourde-Chiche N, Sarlon G, Amoura Z, Harlé JR, Jougla E, Chiche L (2014) Mortality associated with systemic lupus erythematosus in France assessed by multiple-cause-of-death analysis. Arthritis Rheumatol 66(9):2503–2511. https://doi.org/10.1002/art.38731

4. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, Côte R, Grover SA, Fortin PR, Clarke AE, Senécal JL (2001) Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 44(10):2331–2337. https://doi.org/10.1002/1529-0131(200110)44:10%3c2331::aid-art395%3e3.0.co;2-i

5. Kostopoulou M, Nikolopoulos D, Parodis I, Bertsias G (2020) Cardiovascular disease in systemic lupus erythematosus: recent data on epidemiology, risk factors and prevention. Curr Vasc Pharmacol 18(6):549–565. https://doi.org/10.2174/1570161118666191227101636

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Altered Arterial Stiffness, Ventricular–Arterial Coupling and Troponin Levels in Patients with Systemic Lupus Erythematosus;Medicina;2024-05-16

2. Assessment of Arterial Stiffness and Biochemical Markers in Systemic Lupus Erythematosus in the Diagnosis of Subclinical Atherosclerosis;Journal of Personalized Medicine;2024-03-08

3. Cardiac Troponin Serum Concentration Measurement Is Useful Not Only in the Diagnosis of Acute Cardiovascular Events;Journal of Personalized Medicine;2024-02-21

4. Plasma levels of PRO-C3, a type III collagen synthesis marker, are associated with arterial stiffness and increased risk of cardiovascular death;Atherosclerosis;2024-01